EC Number   |
Disease |
PubMed ID |
Title of Publication |
Category |
Confidence Level |
|---|
   3.4.22.33 | Asthma |
498486 |
Allergic reactions, including asthma, to the pineapple protease bromelain following occupational exposure. |
causal interaction
therapeutic application
unassigned |
3
1
0 |
| 3.4.22.33 | Asthma |
627040 |
Asthma caused by bromelin inhalation. |
therapeutic application
unassigned |
1
0 |
| 3.4.22.33 | Asthma |
3691317 |
[Allergic bronchial asthma caused by bromelin] |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
2
0 |
| 3.4.22.33 | Carcinoma, Hepatocellular |
33735410 |
Cytotoxic Effect of Bromelain on HepG2 Hepatocellular Carcinoma Cell Line. |
causal interaction
diagnostic usage
ongoing research
unassigned |
1
3
4
0 |
| 3.4.22.33 | Colitis |
29176974 |
Inhibition of Epithelial TNF-? Receptors by Purified Fruit Bromelain Ameliorates Intestinal Inflammation and Barrier Dysfunction in Colitis. |
causal interaction
ongoing research
therapeutic application
unassigned |
2
4
2
0 |
| 3.4.22.33 | Colitis |
29266133 |
Corrigendum: Inhibition of Epithelial TNF-? Receptors by Purified Fruit Bromelain Ameliorates Intestinal Inflammation and Barrier Dysfunction in Colitis. |
causal interaction
ongoing research
unassigned |
2
1
0 |
| 3.4.22.33 | Cough |
29633783 |
Honey for acute cough in children. |
therapeutic application
unassigned |
1
0 |
| 3.4.22.33 | COVID-19 |
33084621 |
Bromelain: A Review on its Potential as a Therapy for the Management of Covid-19. |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
1
4
0 |
| 3.4.22.33 | Escherichia coli Infections |
11748167 |
Proteolytic inhibition of Salmonella enterica serovar typhimurium-induced activation of the mitogen-activated protein kinases ERK and JNK in cultured human intestinal cells. |
causal interaction
ongoing research
therapeutic application
unassigned |
1
1
1
0 |
| 3.4.22.33 | Hypersensitivity |
3691317 |
[Allergic bronchial asthma caused by bromelin] |
causal interaction
diagnostic usage
therapeutic application
unassigned |
4
3
2
0 |
